Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Australian Journal of Primary Health|March 9, 2013
How integrated are services for patients with chronic obstructive pulmonary disease? Perceptions of patients and health care providersS E Kirby, M Mutimbe, S Vagholkar, et al.
Heart, Lung & Circulation|March 9, 2024
Palliative Care Utilisation and Outcomes in Patients Admitted for Heart Failure in a Victorian Healthcare ServiceSylvia Ye, Cathy Corbett, Adelaide S M Dennis, et al.
Applied and Environmental Microbiology|September 1, 1983
Relation of rumen ATP concentration to bacterial and protozoal numbersD E Nuzback, E E Bartley, S M Dennis, et al.
Lancet (London, England)|July 25, 2000
Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research FrameworkS M Dennis, S J Sharp, M R Vickers, et al.
Plos Pathogens|February 9, 2017
The Malaria Parasite's Lactate Transporter PfFNT Is the Target of Antiplasmodial Compounds Identified in Whole Cell Phenotypic ScreensSanduni V Hapuarachchi, Simon A Cobbold, Sarah H Shafik, et al.
Cell Chemical Biology|July 24, 2018
Defense Peptides Engineered from Human Platelet Factor 4 Kill Plasmodium by Selective Membrane DisruptionNicole Lawrence, Adelaide S M Dennis, Adele M Lehane, et al.
The Journal of Biological Chemistry|February 7, 2019
Characterization of the ATP4 ion pump in Toxoplasma gondiiAdele M Lehane, Adelaide S M Dennis, Katherine O Bray, et al.
Nature Communications|September 30, 2022
A G358S mutation in the Plasmodium falciparum Na+ pump PfATP4 confers clinically-relevant resistance to cipargaminDeyun Qiu, Jinxin V Pei, James E O Rosling, et al.
ACS Central Science|November 2, 2016
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos ArylpyrrolesAlice E Williamson, Paul M Ylioja, Murray N Robertson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2014
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of PlasmodiumMaría Belén Jiménez-Díaz, Daniel Ebert, Yandira Salinas, et al.
Pageof 6